Galectin Therapeutics Inc

GALTNASDAQ · USD
2.91USD-0.07 (-2.35%)
115

Galectin Therapeutics Inc (GALT) Option Chain

Read more

Tracking the GALT option chain helps you see every strike and expiry on Galectin Therapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of GALT options activity at a glance. Use our scanner to monitor the GALT option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For GALT stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where GALT options are being actively traded, and where they are not.

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
2.75200.640.41—1.052.50-16.11—0.750.000.75010197.25
100.0064600.050.00—0.055.00+67.791.452.602.09-0.060250.00
100.001,03500.050.00—0.057.50+151.683.905.104.59-0.09000.00

As of Nov 18, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank15.08% Low
  • Market cap (M$)301
  • 52 weeks high-58.20%
  • 52 weeks low47.52%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$11.00
    278.01% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-16
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.34
  • EPS growth next 5 years—

As of Nov 18, 2026